Expert Highlights

Watch as experts George L. Bakris, MD, Rajiv Agarwal, MD, and Janet McGill, MD, discuss additional clinical pearls on DKD progression and the emerging role of novel non-steroidal MRAs for the treatment of DKD

Interview #1 
Evaluating the Risk for DKD Progression

Watch the experts share some highlights including:

  • Early recognition and screening for DKD
  • Monitoring kidney function
  • Risk factors for DKD progression

 

Interview #2 
The Rationale for Non-Steroidal MRAs in DKD

Watch the experts share some highlights including:

  • Differentiating between steroidal and non-steroidal MRAs
  • Adverse events and limitations with steroidal MRAs in DKD
  • Advantages of finerenone in DKD
  • The overview of kidney results of the FIDELIO trial

 

Interview #3 
The Cardiovascular Benefits of Finerenone

Watch the experts share some highlights including:

  • The interplay between the kidney and heart
  • CVD benefits of finerenone: analysis from the FIDELIO trial and ongoing CVD studies with finerenone
  • How does finerenone fit within the context of SGLT-2is

 

Interview #4 
Finerenone: Putting the Data Into Context

Watch the experts share some highlights including:

  • Finerenone in the context of existing treatments
  • Clinical pearls for incorporating finerenone to the DKD treatment armamentarium in the near future
Return to the DKD Digital Hub